Literature DB >> 26844635

Biomarkers for Heart Failure: An Update for Practitioners of Internal Medicine.

Nicholas Wettersten1, Alan S Maisel2.   

Abstract

Biomarkers have become an integral part of practicing medicine, especially in heart failure. The natriuretic peptides are commonly used in the evaluation of heart failure, but their role extends beyond diagnosis and includes risk stratification and management of heart failure patients. Newer biomarkers have arrived and are becoming part of routine care of heart failure patients. Both ST2 and high-sensitivity troponin have significant prognostic value for mortality, but also may assist in the titration of medical therapy. Procalcitonin can help guide appropriate antibiotic use in patients with heart failure. The ability to appropriately use and interpret these biomarkers is imperative to the care of heart failure patients, especially as these newer biomarkers become widely used. Published by Elsevier Inc.

Entities:  

Keywords:  BNP; Biomarkers; Heart failure; Procalcitonin; ST2; Troponin

Mesh：

Substances：

Year:  2016        PMID： 26844635     DOI： 10.1016/j.amjmed.2016.01.013

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


  15 in total

1.  Biomarkers of Cardiac Disease in Duchenne Muscular Dystrophy are Insufficient in the Absence of Clinical Cardiologic and Neurologic Assessment.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Pediatr Cardiol       Date:  2017-12-16       Impact factor: 1.655

2.  Association of plasma-soluble ST2 and galectin-3 with cardiovascular events and mortality following cardiac surgery.

Authors:  Dipal M Patel; Heather Thiessen-Philbrook; Jeremiah R Brown; Eric McArthur; Dennis G Moledina; Sherry G Mansour; Michael G Shlipak; Jay L Koyner; Peter Kavsak; Richard P Whitlock; Allen D Everett; David J Malenka; Amit X Garg; Steven G Coca; Chirag R Parikh
Journal:  Am Heart J       Date:  2019-12-03       Impact factor: 4.749

Review 3.  Biomarkers in Acute Heart Failure: Diagnosis, Prognosis, and Treatment.

Authors:  Nicholas Wettersten
Journal:  Int J Heart Fail       Date:  2021-02-15

4.  Lack of association between serum syndecan-4, myocardial fibrosis and ventricular dysfunction in subjects with chronic Chagas disease.

Authors:  Ticiana Ferreira Larocca; Carolina Thé Macêdo; Márcia Noya-Rabelo; Luís Cláudio Lemos Correia; Moisés Imbassahy Moreira; Alessandra Carvalho Caldas; Jorge Andion Torreão; Bruno Solano de Freitas Souza; Juliana Fraga Vasconcelos; Alexandre Schaer Carvalho da Silva; Ricardo Ribeiro Dos Santos; Milena Botelho Pereira Soares
Journal:  PLoS One       Date:  2017-12-12       Impact factor: 3.240

5.  A Multiparametric Approach Based on NT-proBNP, ST2, and Galectin3 for Stratifying One Year Prognosis of Chronic Heart Failure Outpatients.

Authors:  Dario Grande; Marta Leone; Caterina Rizzo; Paola Terlizzese; Giuseppe Parisi; Margherita Ilaria Gioia; Tiziana Leopizzi; Antonio Segreto; Piero Guida; Roberta Romito; Marco Matteo Ciccone; Francesca Di Serio; Massimo Iacoviello
Journal:  J Cardiovasc Dev Dis       Date:  2017-07-15

6.  Multi-marker approach using procalcitonin, presepsin, galectin-3, and soluble suppression of tumorigenicity 2 for the prediction of mortality in sepsis.

Authors:  Hanah Kim; Mina Hur; Hee-Won Moon; Yeo-Min Yun; Salvatore Di Somma
Journal:  Ann Intensive Care       Date:  2017-03-07       Impact factor: 6.925

7.  IL-1 family cytokines and soluble receptors in systemic lupus erythematosus.

Authors:  Paola Italiani; Maria Laura Manca; Francesca Angelotti; Daniela Melillo; Federico Pratesi; Ilaria Puxeddu; Diana Boraschi; Paola Migliorini
Journal:  Arthritis Res Ther       Date:  2018-02-08       Impact factor: 5.156

Review 8.  Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player.

Authors:  Marian Wesseling; Julius H C de Poel; Saskia C A de Jager
Journal:  ESC Heart Fail       Date:  2020-05-18

9.  Non-professional marathon running: RAGE axis and ST2 family changes in relation to open-window effect, inflammation and renal function.

Authors:  Christine Bekos; Matthias Zimmermann; Lukas Unger; Stefan Janik; Philipp Hacker; Andreas Mitterbauer; Michael Koller; Robert Fritz; Christian Gäbler; Mario Kessler; Stefanie Nickl; Jessica Didcock; Patrick Altmann; Thomas Haider; Georg Roth; Walter Klepetko; Hendrik Jan Ankersmit; Bernhard Moser
Journal:  Sci Rep       Date:  2016-09-22       Impact factor: 4.379

10.  Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases.

Authors:  Hee Won Moon; Mikyoung Park; Mina Hur; Hanah Kim; Won Hyeok Choe; Yeo Min Yun
Journal:  Ann Lab Med       Date:  2018-07       Impact factor: 3.464
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.